Press release
Varicella Zoster Infections Treatment Market Innovation Accelerates Through Biologics, Vaccines, and Cold Chain Infrastructure
"Global Varicella Zoster Infections Treatment Market reached US$1,799.42 million in 2023 and is expected to reach US$2,523.90 million by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031," according to DataM Intelligence.GSK plc, Pfizer Inc., and Johnson & Johnson hold significant shares, anchored by their shingles vaccine portfolios. Bausch Health, Teva, Viatris, LNHC Inc., Averitas Pharma, and Almatica Pharma LLC contribute antiviral drugs and pain relief options. Meanwhile, Haleon Group specializes in over-the-counter neurologic and analgesic support, making the competitive landscape rich in therapeutic diversity and innovation.
Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/varicella-zoster-infections-treatment-market?jd
Varicella Zoster Treatment Market M&A & Strategic Collaborations
1. GSK-Pfizer Vaccine Collaboration Licensed for Novel Adjuvant Technology (June 2025) to enhance immunogenicity in their next-gen shingles vaccines.
2. Viatris Acquires Averitas Pharma Pipeline Assets (May 2025) to strengthen its antiviral drug offerings, particularly in VZV post-exposure prevention.
3. LNHC Inc. Partners with J&J Consumer Health (July 2025) to develop a combination antiviral analgesic therapy delivered via transdermal patches for shingles pain management.
As per our analysis, these developments emphasize a trend toward vaccine enhancement, antiviral portfolio expansion via licensing and acquisitions, and integrated treatment device collaborations.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/varicella-zoster-infections-treatment-market?jd
Key Growth Drivers & Emerging Opportunities in the Varicella Zoster Treatment Market
• Higher incidence of shingles in aging and immunocompromised populations is elevating vaccine and antiviral demand.
• Adoption of enhanced vaccines with improved efficacy and longer duration (e.g., adjuvanted recombinant vaccines) opens new market avenues.
• Expansion of early diagnostic tools and telehealth platforms for quick VZV diagnosis and pain management.
• Development of combination delivery systems like antiviral-analgesic patches enhances patient compliance and therapeutic effectiveness.
• Strategic licensing and ROFER partnerships are accelerating innovation in prophylactic and therapeutic products.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=varicella-zoster-infections-treatment-market?jd
Regional Market Drivers for Varicella Zoster Infections Treatment
North America leads with universal adult immunization programs, strong public awareness, and insurance-reimbursed antiviral therapy access.
Europe benefits from national vaccine schedules, streamlined approval of adjuvanted vaccines, and extensive primary care networks.
Asia-Pacific exhibits rising demand due to expanding healthcare infrastructure, growing elderly demographics, and vaccine availability initiatives.
Latin America, the Middle East, and Africa are emerging markets where global immunization partnerships, local vaccine production, and improved cold chain capabilities are driving market entry.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Varicella Zoster Infections Treatment Market Innovation Accelerates Through Biologics, Vaccines, and Cold Chain Infrastructure here
News-ID: 4104986 • Views: …
More Releases from DataM Intelligence 4Market Research LLP

United States Electrosurgical Generator Market Growth Driven by Minimally Invasi …
Electrosurgical Generator Market is expected to grow at a CAGR of 6.87% during the forecast period (2024-2031).
Electrosurgical Generators provide controlled electrical energy for cutting, coagulation, and tissue ablation in surgeries. Growth is driven by increasing surgical procedures and demand for minimally invasive techniques. Generators integrate with advanced surgical instruments and monitoring systems. Hospitals, surgical centers, and specialty clinics are key end-users. Technological innovations enhance safety, precision, and energy efficiency. Regulatory…

Pet Probiotics Market to Reach USD 7.1 Billion by 2031 | Growth Driven by Rising …
Global Pet Probiotics Market reached US$ 4,400 million in 2023 and is expected to reach US$ 7,100 million by 2031, growing with a CAGR of 6.16% during the forecast period 2024-2031.
The Pet Probiotics Market includes live microbial supplements that support gut health, immunity, and overall wellness in pets. Growth is driven by increasing pet ownership, awareness of digestive health, and premium pet food demand. Products are available in powders, capsules,…

United States Muscle Stimulator Market Size to Reach USD 1.21 Billion by 2035, G …
The Global Muscle Stimulator Market is predicted to reach at a CAGR of 3.9% during the forecast period (2024-2031).
Muscle Stimulators use electrical impulses to activate muscles for rehabilitation, fitness, or pain management. Growth is driven by rising sports injuries, physiotherapy demand, and aging populations. Devices include TENS, EMS, and neuromuscular electrical stimulation systems. Hospitals, clinics, and homecare settings are primary end-users. Technological advancements in wireless, wearable, and AI-enabled stimulators improve…

United States Climate-Resilient Agriculture Market to Reach US$61.50 Billion by …
The Climate-Resilient Agriculture Market was valued at US$ 26.25 billion in 2024 and is projected to reach US$ 61.50 billion by 2032, growing at a CAGR of 11.23% during the forecast period 2025-2032.
The market focuses on the development and adoption of agricultural systems, technologies, and practices that can withstand and adapt to changing climatic conditions while ensuring food security, sustainable productivity, and environmental conservation.
Rising climate variability, extreme weather events, and…
More Releases for Varicella
Varicella Attenuated Live Vaccination Market Size Analysis by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Varicella Attenuated Live Vaccination market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The varicella attenuated live vaccination market is experiencing steady growth due to rising awareness about the importance of immunization against varicella-zoster virus (chickenpox).…
Global Live Attenuated Varicella Vaccine Market - Opportunities & Forecasts, 202 …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global live attenuated varicella vaccine market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was…
Varicella Live Vaccine Market to Witness Astonishing Growth by 2029
Varicella live vaccine market is anticipated to grow at a significant CAGR during the forecast period. The zoster virus is also known as human alphaherpesvirus 3 which is responsible for causing chickenpox and herpes zoster in the human body. Since the infection which is caused by these viruses is preventable by using vaccines specially formulated to provide immunity against the virus; the market is anticipated to grow substantially in the…
Varicella Live Vaccine Market to Reach $4,222 Million by 2026
Varicella live vaccine market was valued at $2.71 billion in 2018, and is expected to reach $4.22 billion by 2026, registering a CAGR of 5.7% from 2019 to 2026.
Viral infections can be prevented by immunization and therefore, immunization is crucial. Varicella zoster is a virus that causes diseases such as chicken pox and herpes zoster. However, these infectious diseases can be prevented by the use of varicella live vaccines. Varicella…
Varicella Live Vaccine Market Analysis with COVID-19 Effects
According to the report, the varicella live vaccine market was estimated at $2.71 billion in 2018 and is expected to hit $4.22 billion by 2026, registering a CAGR of 5.7% during the study period. The report offers a detailed analysis of the top winning strategies, top investment pockets, drivers & opportunities, market size & estimations, competitive landscape, and wavering market trends.
Increase in immunization programs across the globe, the surge in…
Varicella Live Vaccine Market Expected to Reach $4,222 Million by 2026
According to a new report published by Allied Market Research, titled,"Varicella Live Vaccine Market by Product, Application, and Provider: Global Opportunity Analysis and Industry Forecast, 2018-2026," the global varicella live vaccine market was valued at $2.71 billion in 2018, and is expected to reach $4.22 billion by 2026, registering a CAGR of 5.7% from 2019 to 2026.
Viral infections can be prevented by immunization and therefore, immunization is crucial. Varicella zoster…